microdosing glp 1 for inflammation GLP-1: A New Approach to Inflammation-Driven Diseases Microdosing GLP-1s: Does It Work?

The biggest error researchers make

While these results are certainly encouraging, they should be regarded as preliminary

Realistic 2026 Results: What the Data Shows Metric Typical IF Outcome (1012 Weeks) Weight Loss 711 pounds (roughly 35% of body weight) Fat Loss Primarily visceral (belly) fat Blood Pressure Significant reductions in those with high baseline levels Muscle Retention High (if paired with resistance training) Reduced calorie intake due to fewer meals Improved insulin sensitivity Increased fat burning during fasting periods However, IF does not directly suppress appetite, which is why many people struggle with hunger during fasting hours

Neuroprotective Effect of GLP-1RAs Cognitive dysfunction is a neurodegenerative disorder that impairs multiple cognitive domains, including memory, language, executive function, and spatial orientation, with the extent of impairment correlating with disease severity.107 This spectrum ranges from mild cognitive impairment or mild neurocognitive disorder to more severe forms of dementia, including Alzheimers disease (AD), Parkinsons disease (PD), and vascular dementia

I used to be quite regular on the pooping front, but since starting antihistamines for MCAS I have had to take magnesium oxide to stay regular